• About
  • Contact
Friday, May 9, 2025
  • Login
No Result
View All Result
NEWSLETTER
Now Then Digital
23 °c
Kampala
22 ° Fri
23 ° Sat
23 ° Sun
22 ° Mon
  • HOME
  • NEWS
  • POLITICS
  • BUSINESS
  • TECH
  • ENTERTAINMENT
  • LIFESTYLE
  • TIPS & ADVICE
  • HOME
  • NEWS
  • POLITICS
  • BUSINESS
  • TECH
  • ENTERTAINMENT
  • LIFESTYLE
  • TIPS & ADVICE
No Result
View All Result
Now Then Digital
No Result
View All Result
ADVERTISEMENT
Home National

Ghana Approves High-Efficacy Malaria Vaccine for Children: A Potential “Game-Changer”

A highly effective malaria vaccine designed to prevent disease and death caused by the malaria parasite has been developed by Oxford scientists.

Now Then Digital by Now Then Digital
September 20, 2023
in National, News
Reading Time: 4 mins read
1 0
A A
0
Ghana approves new malaria vaccine for children
0
SHARES
12
VIEWS
Share on FacebookShare on Twitter

The world has been eagerly awaiting the development of an effective malaria vaccine, and now Ghana has become the first country to approve Oxford’s R21 vaccine for children, which has an efficacy rate of 77 percent.

CUPERTINO, CALIFORNIA | NOW THEN DIGITAL — Ghana has granted approval for the use of the world’s second malaria vaccine, a development that has been touted as a major breakthrough in the battle against the parasitic disease.

The vaccine, known as R21/Matrix-M, was created by the esteemed University of Oxford and produced by the Serum Institute of India Pvt Ltd (SIIPL).

The scientists behind this innovative vaccine claim that it has the potential to significantly reduce the number of malaria-related deaths, estimated to be over half a million per year, and improve health outcomes for millions of people, particularly in Africa where malaria is transmitted by mosquitoes.

The World Health Organization (WHO) reports that Africa bears the greatest burden of disease in terms of both morbidity and mortality.

Oxford develops highly effective R21 malaria vaccine
Ghana approves new malaria vaccine with high efficacy rate for children

A Potential Game-Changer

The R21 vaccine, considered by some scientists as a potential “game-changer,” is designed to prevent disease and death rather than transmission. The existing Mosquirix vaccine has an efficacy rate of only 30 to 60 percent. Late-stage testing is still ongoing in several African countries, including Burkina Faso, Kenya, Mali, and Tanzania.

Youmight also like

Ugandan Army Chief Muhoozi Admits Detaining Bobi Wine Bodyguard

Eddie Mutwe Held by Military, Uganda’s Top General Muhoozi Confirms

May 3, 2025
Starlink Eyes East African Expansion with Potential Uganda Launch

Uganda Eyes Satellite Internet Boost as President Museveni Meets Starlink Team

April 29, 2025
Uganda’s Jacob Kiplimo shines with record-breaking marathon debut in London

Uganda’s Jacob Kiplimo shines with record-breaking marathon debut in London

April 28, 2025
Uganda: Latest Ebola outbreak officially over, says health ministry

Uganda: Latest Ebola outbreak officially over, says health ministry

April 26, 2025

While it is unusual for a vaccine to be approved before clinical trials are completed, Ghana has given the green light for children aged five months to three years, who have the highest risk of death from the disease.

Rollout Delayed Until WHO Approval

Despite Ghana’s approval, rollout of the R21 vaccine will be delayed until it is approved by the World Health Organization (WHO). Once approved, Ghana’s drug regulator has a deal with the Serum Institute of India to produce up to 200 million doses per year at a cost of a couple of dollars per dose.

ADVERTISEMENT

A 30-Year Journey

Ghana approves new malaria vaccine
Oxford develops highly effective R21 malaria vaccine

Oxford researchers have been working on the R21 vaccine for 30 years, and their efforts have now culminated in the provision of a high-efficacy vaccine that can be supplied at an adequate scale to the countries most in need.

Once it is approved, the R21 vaccine is expected to be a powerful weapon in the fight against malaria.

In a statement, Professor Adrian Hill, director of the Jenner Institute at Oxford, said the R21 vaccine is the culmination of three decades of malaria vaccine research at Oxford. The new vaccine has been designed to provide protection against the malaria parasite by targeting the proteins that the parasite uses to infect the liver.

The Barriers to Development

Developing a malaria vaccine is not without its challenges, with funding and commercial potential being two of the most significant barriers. Malaria is most prevalent in sub-Saharan Africa, where low-income countries have limited resources for research funding and vaccine development.

However, with the development of the R21 vaccine, there is hope that the vaccine will help to combat the disease and support global efforts to save lives.

According to Adar Poonawalla, CEO of the Serum Institute of India:

“Malaria is a life-threatening disease that disproportionately affects the most vulnerable populations in our society and remains a leading cause of death in childhood.

Poonawalla also expressed his commitment to scaling up production of the vaccine to meet the needs of countries with high malaria burden and to support global efforts to save lives.

Malaria, the Parasitic Disease

Malaria is a parasitic disease that is transmitted by mosquitoes and is most commonly seen in tropical and subtropical climates. It is preventable and curable, but its symptoms range from mild to life-threatening.

Children, pregnant women, and immunocompromised individuals are most at risk, with the most common species in sub-Saharan Africa, Plasmodium falciparum, being the most deadly.

The Need for a Global Response

The release of the R21 vaccine is a significant milestone in the fight against malaria, but it is only the beginning. Eradicating the disease globally will require a coordinated global response and a significant investment in research and development.

Nevertheless, the approval of the R21 vaccine by Ghana is a crucial step forward in the battle against malaria, and it provides hope that a brighter future is on the horizon for millions of people who are affected by this deadly disease.

Editor’s Note: Our content may be inaccurate or out-of-date, so please contact us at press@nowthendigital.com if you see something that needs to be updated.

Source: Now Then Digital
ADVERTISEMENT
Now Then Digital

Now Then Digital

Now Then Digital publish news related to Politics, Entertainment, Sports, Finance and World News. It is owned by Now and Then Entertainment Media in Kampala, Uganda.

Recommended For You

Ugandan Army Chief Muhoozi Admits Detaining Bobi Wine Bodyguard
Politics

Eddie Mutwe Held by Military, Uganda’s Top General Muhoozi Confirms

by Wafula Steven
May 3, 2025
Starlink Eyes East African Expansion with Potential Uganda Launch
News

Uganda Eyes Satellite Internet Boost as President Museveni Meets Starlink Team

by Wafula Steven
April 29, 2025
Uganda’s Jacob Kiplimo shines with record-breaking marathon debut in London
Sports

Uganda’s Jacob Kiplimo shines with record-breaking marathon debut in London

by Now Then Digital
April 28, 2025
Uganda: Latest Ebola outbreak officially over, says health ministry
Health

Uganda: Latest Ebola outbreak officially over, says health ministry

by Wafula Steven
April 26, 2025
ADVERTISEMENT

Related Articles

shein return policy

Shein Return Policy Explained: A Complete Walkthrough for Seamless Returns

3 years ago
Apollo Nyegamehe Dies in Tragic Road Accident

Renowned Ugandan Businessman Apollo Nyegamehe Dies in Tragic Road Accident

2 years ago
MultiChoice Kenya at the 6th Annual Kuza Broadcasting Awards 2023

GOtv Kenya and DStv Kenya Triumph at the 6th Annual Kuza Broadcasting Awards 2023

2 years ago

Popular News

  • Anna Maria von Stockhausen Accused Victim of Superstition

    Who Was Anna Maria von Stockhausen: A Victim of Witch-Hunts in the 18th Century

    0 shares
    Share 0 Tweet 0
  • From Stenographer to Viral Sensation: The Story of Debra Bollman and Her Daughter Sophia’s Rise to Fame

    0 shares
    Share 0 Tweet 0
  • BRICS Group Expands: Six New Member Nations Welcomed

    0 shares
    Share 0 Tweet 0
  • Symptoms and Treatment of Pernicious Anemia Tongue

    0 shares
    Share 0 Tweet 0
  • Key Tips to Identify Fake X Accounts Amid Growing Misinformation

    0 shares
    Share 0 Tweet 0

Connect With Us

Join our Newsletter

Who We Are

Now Then Digital | Breaking News from Uganda & Africa

Latest headlines from Uganda, Africa & the world. Explore politics, entertainment, sports, finance & more on Now Then Digital.

Sign Up For Our Newsletter

Now On Pinterest

Nigeria Tems to perform at Global Citizen Festival 2022 (1)

Global Citizen Festival 2022 Lineup, Burna Boy, Fireboy Album, Movie Room

Uganda National ID Cards Cannot Be Used as Loan Security

NIRA Issues Warning Against Using National IDs for Loans

From Our Partners

  • Editorial Policy
  • Disclaimer
  • Corrections Policy
  • Fact-Checking Policy
  • DMCA Policy

© 2025 Now Then Digital - Breaking News from Uganda, Kenya, Nigeria & South Africa.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
  • Politics
  • Business
  • Entertainment
    • Movies
    • Music
    • Sports
  • Lifestyle
    • Fashion
    • Travel
    • Tech
  • Health
  • Food

© 2025 Now Then Digital - Breaking News from Uganda, Kenya, Nigeria & South Africa.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.